Jakarta (ANTARA) - State-owned pharmaceutical firm PT Kimia Farma forged cooperation with a medical laboratory services provider from Malaysia to foster the development of diagnostic laboratory services.
The cooperation agreed on the provision of assistance and technical knowledge support for the development of diagnostic laboratory services. Thus, through implementation of the collaboration, Kimia Farma can enhance the quality and services of its laboratories.
President Director of PT Kimia Farma David Utama, in his statement here on Wednesday, stated that his firm continues to make efforts to provide easier access to health services to the community through its pharmacy, health clinic, and diagnostic laboratory networks spread across Indonesia.
Related news: Public can already get Sinopharm as booster vaccines: Kimia Farma
"Currently, Kimia Farma has 72 diagnostic laboratories. Kimia Farma took a step to improve laboratory services to (match) international standards through cooperation with Pantai Premier Pathology Sdn. Bhd.," he remarked.
The cooperation between Kimia Farma and Pantai Premier Pathology covers human resource development programs through training and competency improvement, supported by the transfer of knowledge and technology between the two parties.
By exchanging knowledge and technology, Kimia Farma is optimistic of increasing and expanding the range of expertise in the aspect of human resources and service quality.
Related news: TKDN for pharmaceutical industry to be increased to 55 percent
Pantai Premier Pathology Chief Executive Officer Mohd Hareeff Muhammed said his side is honored to be working with Kimia Farma to conduct healthcare transformation and health improvement for Indonesians.
"As one of the providers of comprehensive diagnostic services in Malaysia and part of the IHH Laboratory, we (Pantai Premier Pathology) hope to share knowledge and expertise with Kimia Farma and improve diagnostic services in Indonesia," he remarked.
Through the signing of a memorandum of understanding, Kimia Farma and Pantai Premier Pathology targeted to record an increase in service excellence, human resource skills, and leading technology, so that Kimia Farma can become the best provider in Indonesia.
Related news: Indonesia cuts dependence on Povidone Iodine imports: Minister
Related news: Kimia Farma, SOEs send off hundreds of homecoming travelers
